Home | About Us | Site Map | Contact Us Search

Tools & Resources

Tools & Resources Education Center Clinical Trials Resources Patient Assistance Programs Disease Overviews Disease Resources Charts Fact Sheets Quiz

Disease Resources August-Leukemia July-New Medicines June-Rare Diseases May-Arthritis April-Vaccines March-Diabetes February-Heart Disease

February-Heart Disease

February is American Heart Month

Heart disease is the leading cause of death of Americans. Learn more below about cardiovascular disease, the new medicines that are in development to treat it, and the researchers who are dedicated to improving outcomes for patients.

Heart Disease and Stroke Backgrounder
Click here to learn more about heart disease and stroke, including treatments and progress in current research.

Then & Now – Treatment of High Cholesterol
It's easy to forget, but not very long ago the treatments we might today take for granted hadn't yet been developed. Click here to read about past and present treatment options for high cholesterol and its effects on cardiovascular health.

New Medicines in Development

PhRMA published a report in May 2007 announcing that biopharmaceutical researchers are testing 277 medicines for two of the three leading causes of death of Americans: heart disease and stroke. Click here to read the full report and also find links to more Innovation.org resources on current cardiovascular research and innovations.

Recent FDA Approvals for Cardiovascular Disease

Bystolic^TM– nebivolol hydrochloride – approved 12/17/2007. For the treatment of high blood pressure
Ammonia N 13 – ammonia, N-13 – approved 8/23/2007 A radioactive diagnostic agent for Positron Emission Tomography (PET), for diagnostic PET imaging of the myocardium under rest or pharmacologic stress conditions to evaluate myocardial perfusion in patients with suspected or existing coronary artery disease
Letairis^TM – ambrisentan – approved 6/15/2007 For the treatment of pulmonary arterial hypertension
Tekturna^TM – aliskiren – approved 3/6/2007 For the treatment of hypertension
Ranexa^® – ranolazine – approved 1/27/2006 For the treatment of chronic angina

Click here for a full list of recent FDA approvals in all disease areas.

Featured Studies and Reports
As part of its ongoing effort to encourage new research and pharmaceutical innovation, Innovation.org highlights key studies and reports into critical disease areas. Read about new studies in cardiovascular disease.

Study Shows Hypertension Treatment and Control Better in the United States than Western Europe (July 18, 2007) Read more
Rate of Heart Attack Deaths and Heart Failure Decline (June 8, 2007) Read more

Charts
Review the charts below for recent analysis specific to cardiovascular disease.

Click here to view all of Innovation.org’s charts.